These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37108666)
21. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
22. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma. Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C Front Immunol; 2023; 14():1171883. PubMed ID: 37056778 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of Wang T; Xie F; Li YH; Liang B Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468 [TBL] [Abstract][Full Text] [Related]
24. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database. Chen B; Chen W; Jin J; Wang X; Cao Y; He Y Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309 [TBL] [Abstract][Full Text] [Related]
25. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics. Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501 [TBL] [Abstract][Full Text] [Related]
26. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J Front Immunol; 2023; 14():1102824. PubMed ID: 37122750 [TBL] [Abstract][Full Text] [Related]
27. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database. Wan B; Liu B; Huang Y; Lv C Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488 [TBL] [Abstract][Full Text] [Related]
28. MUC20 as a novel prognostic biomarker in ccRCC correlating with tumor immune microenvironment modulation. Xue B; Guo WM; Jia JD; Kadeerhan G; Liu HP; Bai T; Shao Y; Wang DW Am J Cancer Res; 2022; 12(2):695-712. PubMed ID: 35261796 [TBL] [Abstract][Full Text] [Related]
29. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma. Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S Front Immunol; 2022; 13():1048204. PubMed ID: 36505496 [TBL] [Abstract][Full Text] [Related]
30. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma. Long Q; Huang C; Huang J; Meng Q; Cheng Y; Li Y; He L; Chen M; Zhang C; Wang X; Zhu W; Peng J; Shi D; Zheng F; Dong P; Deng W J Adv Res; 2022 Sep; 40():153-166. PubMed ID: 36100323 [TBL] [Abstract][Full Text] [Related]
32. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment. Xu W; Liu WR; Xu Y; Tian X; Anwaier A; Su JQ; Zhu WK; Shi GH; Wei GM; Huang YP; Qu YY; Zhang HL; Ye DW Int J Biol Sci; 2021; 17(9):2205-2222. PubMed ID: 34239350 [No Abstract] [Full Text] [Related]
33. Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042 [TBL] [Abstract][Full Text] [Related]
34. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma. Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z Front Immunol; 2022; 13():934243. PubMed ID: 36189255 [TBL] [Abstract][Full Text] [Related]
36. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895 [TBL] [Abstract][Full Text] [Related]
37. Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value. Wang Y; Yang J; Zhang Q; Xia J; Wang Z Transl Androl Urol; 2019 Dec; 8(6):609-618. PubMed ID: 32038957 [TBL] [Abstract][Full Text] [Related]
38. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. Zhou S; Lu Y; Chen Y; Gan W Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108 [TBL] [Abstract][Full Text] [Related]
39. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
40. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma. Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]